Standard BioTools Inc. FLDM
Set alert
3.71 +3.71 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 294.19M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -3.53
- Beta
- 1.14
- Short ratio
- 8.42
- Inst. own
- 99.98%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 5, 2022
- 50-d avg
- 3.63
- 200-d avg
- 4.86
- 1y target
- 6.00
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 6.00
Ratings (0m) 2 0 buy · 2 hold · 0 sell
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 1
- 2 months ago 1
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -0.25 | 0.0% | 25.60M | -21.9% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.23 | 0.0% | 29.80M | -3.9% | 0 |
| Current year | -1.00 | -1.00 – -1.00 | -0.78 | -28.2% | 124.40M | -4.7% | 1 |
| Next year | -1.05 | -1.05 – -1.05 | -1.00 | -5.0% | 136.60M | +9.8% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 27, 2020 | UBS | Maintained | — | Buy |
| Aug 10, 2020 | UBS | Maintained | — | Buy |
| Nov 6, 2019 | Janney Capital | Downgrade | Buy | Neutral |
| Oct 18, 2019 | UBS | Upgrade | Neutral | Buy |
| Mar 15, 2019 | UBS | Initiated | — | Neutral |
| Mar 14, 2019 | BTIG Research | Initiated | — | Buy |
| Jan 3, 2019 | Janney Capital | Upgrade | Neutral | Buy |
| Nov 2, 2018 | PiperJaffray | Upgrade | Neutral | Overweight |
| Feb 5, 2016 | Mizuho | Upgrade | Neutral | Buy |
| Feb 4, 2016 | Deutsche Bank | Maintained | — | Buy |
| Jan 20, 2016 | Cowen & Co. | Downgrade | Outperform | Market Perform |
| Jan 6, 2016 | Avondale Partners | Initiated | — | Market Outperform |
| Jan 6, 2016 | Deutsche Bank | Initiated | — | Buy |
| Nov 2, 2015 | Cantor Fitzgerald | Upgrade | Hold | Buy |
| Oct 30, 2015 | Cantor Fitzgerald | Upgrade | Hold | Buy |
| Oct 1, 2015 | Cowen & Co. | Maintained | — | Outperform |
| Aug 27, 2015 | Cantor Fitzgerald | Initiated | — | Hold |
| Aug 7, 2015 | PiperJaffray | Downgrade | Overweight | Neutral |
| May 8, 2015 | Leerink Swann | Maintained | — | Outperform |
| May 8, 2015 | Mizuho | Downgrade | Buy | Neutral |
| Mar 5, 2015 | Leerink Swann | Maintained | — | Outperform |
| Jan 20, 2015 | Cowen & Co. | Upgrade | Market Perform | Outperform |
| May 5, 2014 | PiperJaffray | Maintained | — | Overweight |
| Apr 14, 2014 | Leerink Swann | Upgrade | Market Perform | Outperform |
| Feb 7, 2014 | Cowen & Co. | Downgrade | Outperform | Market Perform |
| Jun 27, 2013 | Maxim Group | Initiated | — | — |
| Apr 29, 2013 | Leerink Swann | Downgrade | Outperform | Market Perform |
| Oct 9, 2012 | Mizuho | Downgrade | Buy | Neutral |
| Jun 27, 2012 | Cantor Fitzgerald | Initiated | — | Buy |